GMED Stock Rises on Q1 Earnings & Revenue Beat, '26 EPS View Raised

Globus Medical beats Q1 EPS estimates by 22% as revenues rise 27% to $759.9M; margins widen and 2026 EPS outlook up, lifting shares 5.8%.